Acetaminophen and chronic post-surgical neuropathic pain: a randomized double blind cross-over study

Clicks: 12
ID: 334109
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #83 of 84 articles by views in regional anesthesia and pain medicine

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
OBJECTIVE: Despite not being recommended in treatment algorithms, people often take acetaminophen for pain relief in neuropathic pain. As there is no randomized clinical trial on oral acetaminophen in neuropathic pain, this study aims to evaluate the efficacy of oral therapeutic-dose acetaminophen compared to placebo in patients with peripheral neuropathic pain. DESIGN: This is a randomized, placebo-controlled, crossover, double-blind clinical study. The protocol and informed consent form were approved by the French Research Ethics Committee and National Drug Agency (trial number: NCT03559985). SETTING: It took place in University Hospital, Clermont-Fd, France. SUBJECTS: Thirty patients with chronic post-surgery neuropathic pain were randomised. METHODS: Acetaminophen or placebo was taken for 7 days with a wash-out period of 7 days and treatments were compared. Outcomes were 7-day mean pain intensity (numerical rating scale) after treatment, Neuropathic Pain Symptom Inventory (NPSI), Patient Global Impression of Change (PGIC), Hospital Anxiety and Depression Scale (HAD), Pittsburgh Sleep Quality Index (PSQI), and adverse events. RESULTS: Acetaminophen presents no statistical difference with the placebo for pain report (effect-size [95%CI]: -0.09 [-0.45; 0.26], P = 0.607) and for all secondary outcomes. CONCLUSIONS: This study demonstrates no clinically meaningful analgesic benefit of short-term, 3g/day oral acetaminophen as add-on therapy in chronic post-surgical peripheral neuropathic pain, and no adverse events. Although findings should not be generalized, patients with neuropathic pain using self-medicated acetaminophen should always be informed about the risks of long-term use of acetaminophen to avoid unnecessary intake and potential long term adverse events.
Reference Key
openalex_W7223701040 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Christelle Gimenez, Véronique Morel, Bruno Pereira, Marie‐Eva Pickering, Rosalie Bervas, Roger Knaggs, Nicolas Macian, Gisele P Pickering
Journal regional anesthesia and pain medicine
Year 2026
DOI
10.1093/pm/pnag125
URL
https://doi.org/10.1093/pm/pnag125
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.